Table 1.
Baseline characteristics and clinical presentation.
| Patients (n = 15) | |
|---|---|
| Age | 67.8 ± 14.4 |
| Male | 10 (66.7) |
| Hypertension | 8 (53.3) |
| Dyslipidaemia | 5 (33.3) |
| Diabetes mellitus | 3 (20.0) |
| Chronic pulmonary disease | 4 (26.7) |
| Prior myocardial infarction | 3 (20.0) |
| Previous percutaneous coronary intervention | 5 (33.3) |
| Previous coronary artery bypass graft | - |
| Chronic kidney disease * | 4 (26.7) |
| Dialysis | 2 (13.3) |
| Atrial fibrillation | 4 (26.7) |
| Prior transient ischaemic attack or stroke | 2 (13.3) |
| Peripheral artery disease | 1 (6.7) |
| Chronic heart failure | 2 (13.3) |
| Left ventricular ejection fraction, % | 32.9 ± 13.7 |
| Right ventricular dysfunction | 15 (100) |
| Out-of-hospital cardiac arrest | 2 (13.3) |
| Aetiology of cardiogenic shock | |
| ST-elevation myocardial infarction | 6 (40.0) |
| Acute myocarditis | 2 (13.3) |
| Other | 7 (46.7) |
| Haemodynamic Values | |
| Heart rate, bpm | 85.9 ± 25.0 |
| Mean arterial pressure, mmHg | 65.2 ± 11.2 |
| Laboratory values | |
| pH | 7.34 ± 0.1 |
| Serum lactate, mmol/L | 5.1 ± 3.9 |
| Haemoglobin, g/dL | 12.2 ± 2.0 |
| Serum creatinine, mg/dL | 2.1 ± 1.2 |
Results are reported as n (%) and mean ± standard deviation as appropriate. * Defined as eGFR < 60 mL/min/1.73 m2. One patient suffered from RVF after transapical TAVI; one patient suffered from RVF after mitral valve replacement surgery.